Jardenico, Leo T.
HRN: 26-79-50 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/29/2025
CEFTAZIDIME 1GM (VIAL)
04/29/2025
05/06/2025
IV
1g
Q8
T/c Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractPneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes